• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • Trump Administration
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • Trump Administration
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Pharmaceutical Industry

    Tag: Pharmaceutical Industry

    Sen. Claire McCaskill, D-Mo., speaks at the dedication for Gateway Arch National Park Tuesday, July 3, 2018, in St. Louis. The $380 million renovation to the park surrounding the Gateway Arch is the first major renovation since the monument opened in 1965 and one Missouri political leaders see as a template for the future of the national park system.
    Healthcare

    Letting Medicare negotiate drug prices could save nearly $3 billion: Democratic report

    Robert King -
    August 1, 2018 3:03 pm
    0
    Despite price hikes, older drugs weigh on Pfizer’s profits
    Business

    Despite price hikes, older drugs weigh on Pfizer’s profits

    Joe Williams -
    July 31, 2018 9:43 am
    0
    Midterm election candidates attacked over high drug prices
    Healthcare

    Midterm election candidates attacked over high drug prices

    Robert King -
    July 31, 2018 12:00 am
    0
    The failures of UK's National Health Service serves as a warning for what the Affordable Care Act will do to health care in the U.S. (Photo: Thinkstock)
    Beltway Confidential

    The real reason to be skeptical of single-payer healthcare is not cost but government mismanagement

    Erin Dunne -
    July 30, 2018 10:25 pm
    0
    A sign reads "Consultation" at the pharmacy window inside a Walgreens Boots Alliance Inc. store in the Hollywood neighborhood of Los Angeles, California, on Oct. 19, 2017.
    Healthcare

    House lawmakers want federal probe of drug middlemen mergers

    Robert King -
    July 27, 2018 7:29 pm
    0
    Lawmakers aim to stop use of pill machines used to boost opioid epidemic
    Healthcare

    Lawmakers aim to stop use of pill machines used to boost opioid epidemic

    Robert King -
    July 26, 2018 9:03 pm
    0
    Trump administration calls for more cuts to drug discount program for safety net hospitals
    Healthcare

    Trump administration calls for more cuts to drug discount program for safety net hospitals

    Robert King -
    July 25, 2018 10:18 pm
    0
    FILE - In this file photo taken Thursday, Feb. 9, 2012, a pharmacist is seen working in a lab where medicines are being produced at a manufacturing unit on the outskirts of Mumbai, India. India's patent office on Monday march 12, 2012  effectively ended Bayer's monopoly on a patented cancer drug by allowing the manufacturing of a generic copy at a fraction of the price.
    Healthcare

    Eli Lilly opposes using imports to tackle high drug prices

    Robert King -
    July 24, 2018 2:27 pm
    0
    Bob Hugin, a Republican candidate running in in next week's New Jersey primary election for U.S. Senate, talks with constituents during the Monmouth GOP Super Saturday campaign drive, Saturday, June 2, 2018, in Colts Neck, N.J.
    Healthcare

    New Jersey Senate candidate doubled price of vital cancer drug, group charges

    Robert King -
    July 23, 2018 3:28 pm
    0
    The Merck logo is seen on a stained glass panel at a Merck company building in Kenilworth, N.J.
    Healthcare

    Merck promises to avoid large price hikes under Trump pressure

    Robert King -
    July 19, 2018 7:47 pm
    0
    1...808182...159Page 81 of 159
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.